Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HSV-2 Genital Herpes”

62 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 62 results

Post-approval studies (Phase 4)Study completedNCT00723229
What this trial is testing

Trial to Evaluated the Suppressive Effect of Acyclovir on Rapidly Cleared HSV-2 Reactivation

Who this might be right for
Genital Herpes
University of Washington 48
Large-scale testing (Phase 3)Ended earlyNCT00122525
What this trial is testing

Effect of Male Circumcision on HIV Incidence (ANRS 1265)

Who this might be right for
HIV InfectionsHerpes GenitalisVenereal Diseases
French National Agency for Research on AIDS and Viral Hepatitis 3,274
Testing effectiveness (Phase 2)Study completedNCT02114060
What this trial is testing

Dose Ranging Safety and Efficacy of Therapeutic HSV-2 Vaccine

Who this might be right for
Genital Herpes Simplex Type 2
Genocea Biosciences, Inc. 310
Post-approval studies (Phase 4)Study completedNCT00306293
What this trial is testing

VALTREX(Valacyclovir) Once Daily for Viral Shedding In Subjects Newly Diagnosed With HSV-2

Who this might be right for
Herpes Labialis
GlaxoSmithKline 70
Testing effectiveness (Phase 2)Study completedNCT02300142
What this trial is testing

Rollover Trial for Placebo Subjects Previously Enrolled Into GEN-003-002 Study

Who this might be right for
Genital Herpes Simplex Type 2
Genocea Biosciences, Inc. 37
Not applicableStudy completedNCT02910284
What this trial is testing

Long-term Follow-up of GEN-003-002 Subjects for Efficacy and Immunogenicity

Who this might be right for
Genital Herpes Simplex Type 2
Genocea Biosciences, Inc. 140
Not applicableStudy completedNCT00495573
What this trial is testing

HSV-2 Shedding Resolution After Acyclovir Treatment

Who this might be right for
Genital Herpes
University of Washington 36
Testing effectiveness (Phase 2)Study completedNCT01047540
What this trial is testing

Safety and Efficacy Study for a New Antiviral Drug to Treat Genital Herpes Type 2

Who this might be right for
HSV-2
AiCuris Anti-infective Cures AG 156
Early research (Phase 1)Study completedNCT00231049
What this trial is testing

Trial Evaluating Safety, Tolerability and Immune Response of AG-707

Who this might be right for
Genital Herpes
Agenus Inc. 35
Testing effectiveness (Phase 2)Not Yet RecruitingNCT04979975
What this trial is testing

Evaluating Safety and Efficacy of Repeat Doses of UB-621in Adult Patients With Recurrent Genital Herpes

Who this might be right for
Recurrent Genital Herpes
UBP Greater China (Shanghai) Co., Ltd 200
Post-approval studies (Phase 4)Study completedNCT00161434
What this trial is testing

Valacyclovir to Suppress HSV and HIV Shedding in Coinfected Persons

Who this might be right for
Herpes SimplexHIV Infections
University of Washington 60
Large-scale testing (Phase 3)Study completedNCT00164424
What this trial is testing

Episodic Acyclovir Therapy for Genital Ulcers

Who this might be right for
HIV InfectionsUlcerHerpes Simplex
Centers for Disease Control and Prevention 613
Not applicableStudy completedNCT04664127
What this trial is testing

Study of the Efficacy and Safety of Combined Treatment of Patients With Severe Herpes Simplex (HSV) Infection by Valacyclovir and Interferon Inducer Kagocel

Who this might be right for
HerpesHerpes SimplexHerpes Oral+2 more
Nearmedic Plus LLC 45
Post-approval studies (Phase 4)Study completedNCT01026454
What this trial is testing

Valacyclovir vs. Acyclovir as HSV-2 Suppressive Therapy: Effect on Plasma HIV-1 Levels Among HIV-1/HSV-2 Co-infected Persons

Who this might be right for
HSV InfectionHIV Infection
University of Washington 32
Testing effectiveness (Phase 2)Study completedNCT02030301
What this trial is testing

Safety and Efficacy Trial of DNA Vaccines to Treat Genital Herpes in Adults

Who this might be right for
Genital Herpes Simplex Type 2
Vical 165
Early research (Phase 1)Ended earlyNCT04222985
What this trial is testing

Safety and Efficacy of 4 Investigational HSV 2 Vaccines in Adults With Recurrent Genital Herpes Caused by HSV 2

Who this might be right for
Genital Herpes
Sanofi Pasteur, a Sanofi Company 24
Testing effectiveness (Phase 2)Study completedNCT02837575
What this trial is testing

Safety and Efficacy Study of Herpes Simplex Virus Type 2 (HSV-2) Therapeutic DNA Vaccine

Who this might be right for
Herpes Genitalis
Vical 261
Testing effectiveness (Phase 2)Ended earlyNCT03146403
What this trial is testing

Maintenance Dose Study of GEN-003 in Subjects With Genital Herpes Infection

Who this might be right for
Genital HerpesHSV-2 Infection
Genocea Biosciences, Inc. 33
Post-approval studies (Phase 4)Study completedNCT00362297
What this trial is testing

Randomized Trial to Evaluate Suppressive Effect of High-Dose Acyclovir Versus Once-Daily Valacyclovir on Persons With HSV-2

Who this might be right for
Genital Herpes
University of Washington 31
Early research (Phase 1)Enrolling By InvitationNCT07330440
What this trial is testing

A Phase I Study to Evaluate the Safety, Tolerability, and Immunogenicity of an mRNA Vaccine Against Herpes Simplex Virus Type 2 (HSV-2) Post-Vaccination

Who this might be right for
Genital Herpes
Changchun BCHT Biotechnology Co. 144
Next Page